Get the latest NAV of ICICI Prudential Nifty Pharma Index Fund Direct Growth. View historical returns compared to its benchmark and category average. Know which stocks and sectors the fund is investing in. Get an estimate of returns from the SIP and lump sum returns calculator. View detailed holding analysis and peer comparison. Get INDmoney ranking of the fund.
₹16.69
1D
NAV as on 16 May 2025
23.89%/per year
Since Inception
▲▼
884 people have invested ₹ 43.1L in ICICI Prudential Nifty Pharma Index Fund Direct Growth in the last three months
Calculate SIP and lumpsum returns based on historical performance
Total Investment
0
Profit
Total Corpus
0
See fund asset allocation details as on (13-May-25)
Fund Distribution
as on (13-May-25)
Equity 99.9%
Debt & Cash 0.1%
See fund sector allocation details as on (13-May-25)
Sector Allocation
Equity 99.9%
Debt & Cash 0.1%
Top Sector in April was Health
Health
100%
Health
100%
as on (30-Apr-25)
Equity
Get key fund statistics, minimum investment details, AUM, expense ratio, exit load, and tax treatment.
Expense ratio | 0.37% |
Benchmark | Nifty Pharma TR INR |
AUM | ₹83 Cr |
Inception Date | 15 December, 2022 |
Min Lumpsum/SIP | ₹1000/₹1000 |
Exit Load | 0% |
Lock In | No Lock-in |
TurnOver | 3.54% |
STCG | Selling mutual fund before 1 year, returns taxed at 20%. |
LTCG | After 1 year, 12.5% tax on returns over ₹1.25 lakh/year. |
Risk | Very High Risk |
ICICI Prudential Nifty Pharma Index Fund Direct Growth is an equity fund. This fund was started on 15 December, 2022. The fund is managed by Nishit Patel. The fund could potentially beat inflation in the long-run.
ICICI Prudential Nifty Pharma Index Fund Direct Growth has given a CAGR return of 23.89% since inception. Over the last 1 year the fund has given a CAGR return of 13.91%.
ICICI Prudential Nifty Pharma Index Fund Direct Growth has allocated its funds majorly in Health, Cash Equivalent. Its top holdings are Sun Pharmaceuticals Industries Ltd, Cipla Ltd, Divi's Laboratories Ltd, Dr Reddy's Laboratories Ltd, Lupin Ltd
As it is a index funds mutual fund the taxation is as follows:For short term (less than a year) capital gains will be taxed at 20%For long term (more than 1 year) capital gains will be taxed at 12.5% without indexation benefitDividends will always be taxed at slab rate. Long term gains upto Rs 1 lakh are exempt capital gains tax.
The objective of the Scheme is to invest in companies whose securities are included in Nifty Pharma Index and subject to tracking errors, to endeavor to achieve the returns of the above index. This would be done by investing in all the stocks comprising the Nifty Pharma Index in the same weightage that they represent in Nifty Pharma Index. However, there is no assurance or guarantee that the investment objective of the scheme shall be achieved.
Minimum investment for lump sum payment is INR 1000.00 and for SIP is INR 1000.00. ICICI Prudential Nifty Pharma Index Fund Direct Growth has no lock in period.
Fund Manager of ICICI Prudential Nifty Pharma Index Fund Direct Growth, since 15 December 2022
5Y CAGR
▲ 41.48
5Y CAGR
▲ 36.48
5Y CAGR
▲ 34.37
5Y CAGR
▲ 36.49
ICICI Prudential Nifty Pharma Index Fund Direct Growth | Absolute Returns | CAGR Returns |
1 Month Returns | 3.61% | 3.61% |
6 Month Returns | -0.42% | -0.42% |
1 Year Returns | 13.91% | 13.91% |
3 Years Returns | 0% | 0% |
Fund Name | Alpha 1 Year | Alpha 3 Years | Alpha 5 Years |
ICICI Prudential Nifty Pharma Index Fund Direct Growth | -0.62 | - | - |
Fund Name | Beta 1 Year | Beta 3 Years | Beta 5 Years |
ICICI Prudential Nifty Pharma Index Fund Direct Growth | 1 | - | - |
Fund Name | Sharpe Ratio 1 Year | Sharpe Ratio 3 Years | Sharpe Ratio 5 Years |
ICICI Prudential Nifty Pharma Index Fund Direct Growth | 0.45 | - | - |
Fund Name | Standard Deviation 1 Year | Standard Deviation 3 Years | Standard Deviation 5 Years |
ICICI Prudential Nifty Pharma Index Fund Direct Growth | 20.27 | - | - |